Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Exogenous hormone administration and kidney health outcomes in females treated with in-vitro fertilization
EF 2022-23
Résumé
In-vitro fertilization (IVF), a form of fertility treatment, is presently responsible for ~2% of live births in Canada. IVF involves administration of high doses of sex hormones and results in increased egg production in the ovaries. Although we know that sex hormones can influence kidney function, it is not yet clear how hormone administration in IVF specifically impacts females’ future kidney health. Thus, the purpose of this study is to examine the relationship between hormone administration in IVF and important markers of kidney health. Healthy female participants planning to participate in IVF treatment will be recruited to complete two physiology study visits in our laboratory in Calgary, Alberta. The first visit will be a baseline visit prior to initiation of IVF treatment. At this visit, a detailed health history and physical examination will be completed. Baseline hormone levels will be assessed through a blood draw and physiologic assessment of kidney health will be completed. The second visit, timed at the peak of the hormone administration portion of their IVF treatment, will involve repeat assessment of hormone levels using a blood draw and repeat physiologic assessment of their kidney health. Changes in each participant’s kidney health, as well as changes in their hormone levels will be compared to understand the effects of hormone administration in IVF on kidney health. One in 10 Canadian females have chronic kidney disease, which highlights the importance of maintaining kidney health. To our knowledge, this is the first study to directly assess the effect of hormone administration in IVF on kidney health in females, and it will provide critical information to assist females and their care providers in decision-making and kidney risk reduction.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486339
Name
Kharbanda Sakshi
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exogenous hormone administration and kidney health outcomes in females treated with in-vitro fertilization
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Glomerular Filtration (Gfr); In-Vitro Fertilization (Ivf); Infertility; Kidney Function; Ovarian Stimulation
Abstract
In-vitro fertilization (IVF), a form of fertility treatment, is presently responsible for ~2% of live births in Canada. IVF involves administration of high doses of sex hormones and results in increased egg production in the ovaries. Although we know that sex hormones can influence kidney function, it is not yet clear how hormone administration in IVF specifically impacts females’ future kidney health. Thus, the purpose of this study is to examine the relationship between hormone administration in IVF and important markers of kidney health. Healthy female participants planning to participate in IVF treatment will be recruited to complete two physiology study visits in our laboratory in Calgary, Alberta. The first visit will be a baseline visit prior to initiation of IVF treatment. At this visit, a detailed health history and physical examination will be completed. Baseline hormone levels will be assessed through a blood draw and physiologic assessment of kidney health will be completed. The second visit, timed at the peak of the hormone administration portion of their IVF treatment, will involve repeat assessment of hormone levels using a blood draw and repeat physiologic assessment of their kidney health. Changes in each participant’s kidney health, as well as changes in their hormone levels will be compared to understand the effects of hormone administration in IVF on kidney health. One in 10 Canadian females have chronic kidney disease, which highlights the importance of maintaining kidney health. To our knowledge, this is the first study to directly assess the effect of hormone administration in IVF on kidney health in females, and it will provide critical information to assist females and their care providers in decision-making and kidney risk reduction.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kharbanda, Sakshi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~